J. Patel

发表

Synovial sarcomas true carcinosarcomas?

M. Leader, J. Patel, M. Collins, 1987, Cancer.

Vimentin: an evaluation of its role as a tumour marker

M. Leader, K. Henry, J. Patel, 1987, Histopathology.

Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.

M. Leader, K. Henry, J. Patel, 1986, Journal of clinical pathology.

Cytoarchitectural and kinetic features in the histological evaluation of follicular thyroid neoplasms

S. Diaz-Cano, J. Patel, S. Arif, 2007, Histopathology.

Staining for factor VIII related antigen and Ulex europaeus agglutinin I (UEA‐I) in 230 tumours. An assessment of their specificity for angiosarcoma and Kaposi's sarcoma

M. Leader, K. Henry, J. Patel, 1986, Histopathology.

Desmin: Its value as a marker of muscle derived tumours using a commercial antibody

M. Leader, K. Henry, J. Patel, 2004, Virchows Archiv A.

Metastatic pattern of malignant melanoma. A study of 216 autopsy cases.

M. Didolkar, J. Pickren, R. Moore, 1978, American journal of surgery.

Anti—α1-Antichymotrypsin Staining of 194 Sarcomas, 38 Carcinomas, and 17 Malignant Melanomas Its Lack of Specificity as a Tumour Marker

M. Leader, K. Henry, J. Patel, 1987, The American journal of surgical pathology.

Myoglobin: an evaluation of its role as a marker of rhabdomyosarcomas.

M. Leader, K. Henry, J. Patel, 1989, British Journal of Cancer.

Case Study of Renal Cell Carcinoma

J. Patel, V. S. Green, 1997 .

An analysis of the sensitivity and specificity of the cytokeratin marker CAM 5.2 for epithelial tumours. Results of a study of 203 sarcomas, 50 carcinomas and 28 malignant melanomas

M. Leader, K. Henry, J. Patel, 1986, Histopathology.